trimethoprim has been researched along with Vibrio cholerae Infection in 19 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The persistence of Vibrio cholerae, biotype el tor, in a patient treated with trimethoprim-sulfamethoxazole was due to the acquisition of a conjugative resistance plasmid." | 7.67 | Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole. ( Couetdic, G; Dupont, MJ; Jouvenot, M; Michel-Briand, Y, 1985) |
| "The efficacy of trimethoprim-sulphamethoxazole (TMP-SMX) has been compared with that of tetracycline and chloramphenicol in 175 bacteriologically confirmed cases of cholera admitted to the Infectious Diseases Hospital Delhi." | 7.66 | Effect of trimethoprim-sulphamethoxazole on vibrio clearance in cholera (El Tor): a comparative study. ( Dutta, JK; Misra, BS; Ray, SN; Santhanam, S, 1978) |
| "67 of the bacteriologically proved adult acute cholera patients have been examined in order to evaluate the efficacy of TM-SMX in comparison with tetracycline and chloramphenicol in the eradication of Vibrio cholerae from stools." | 7.65 | Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol. ( Fera, G; Pastore, G; Rizzo, G; Schiraldi, O, 1977) |
| "Two novel integron-borne cassettes, dfrA27 (encoding trimethoprim resistance) and aadA16 (encoding streptomycin and spectinomycin resistance), located on a conjugative plasmid, have been found in a non-O1, non-O139 Vibrio cholera isolate." | 3.76 | Characterization of two novel gene cassettes, dfrA27 and aadA16, in a non-O1, non-O139 Vibrio cholerae isolate from China. ( Ni, Y; Sun, J; Wu, Q; Zhou, M, 2010) |
| "The persistence of Vibrio cholerae, biotype el tor, in a patient treated with trimethoprim-sulfamethoxazole was due to the acquisition of a conjugative resistance plasmid." | 3.67 | Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole. ( Couetdic, G; Dupont, MJ; Jouvenot, M; Michel-Briand, Y, 1985) |
| "The efficacy of trimethoprim-sulphamethoxazole (TMP-SMX) has been compared with that of tetracycline and chloramphenicol in 175 bacteriologically confirmed cases of cholera admitted to the Infectious Diseases Hospital Delhi." | 3.66 | Effect of trimethoprim-sulphamethoxazole on vibrio clearance in cholera (El Tor): a comparative study. ( Dutta, JK; Misra, BS; Ray, SN; Santhanam, S, 1978) |
| "67 of the bacteriologically proved adult acute cholera patients have been examined in order to evaluate the efficacy of TM-SMX in comparison with tetracycline and chloramphenicol in the eradication of Vibrio cholerae from stools." | 3.65 | Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol. ( Fera, G; Pastore, G; Rizzo, G; Schiraldi, O, 1977) |
| "Vibrio cholerae has frequently experienced genetic changes with rapid evolution of pandemic clones in the Ganges Delta region." | 1.48 | Comparative genomics of Vibrio cholerae O1 isolated from cholera patients in Bangladesh. ( Begum, A; Dalsgaard, A; Hendriksen, RS; Hossain, ZZ; Jensen, PKM; Leekitcharoenphon, P; Sultana, R, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (52.63) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, H | 1 |
| Burkinshaw, BJ | 1 |
| Lam, LG | 1 |
| Manera, K | 1 |
| Dong, TG | 1 |
| Hossain, ZZ | 1 |
| Leekitcharoenphon, P | 1 |
| Dalsgaard, A | 1 |
| Sultana, R | 1 |
| Begum, A | 1 |
| Jensen, PKM | 1 |
| Hendriksen, RS | 1 |
| Eibach, D | 1 |
| Herrera-León, S | 1 |
| Gil, H | 1 |
| Hogan, B | 1 |
| Ehlkes, L | 1 |
| Adjabeng, M | 1 |
| Kreuels, B | 1 |
| Nagel, M | 1 |
| Opare, D | 1 |
| Fobil, JN | 1 |
| May, J | 1 |
| Rajpara, N | 1 |
| Patel, A | 1 |
| Tiwari, N | 1 |
| Bahuguna, J | 1 |
| Antony, A | 1 |
| Choudhury, I | 1 |
| Ghosh, A | 2 |
| Jain, R | 1 |
| Bhardwaj, AK | 1 |
| Mandal, S | 1 |
| Pal, NK | 1 |
| Chowdhury, IH | 1 |
| Debmandal, M | 1 |
| Sun, J | 1 |
| Zhou, M | 1 |
| Wu, Q | 1 |
| Ni, Y | 1 |
| Rashed, SM | 1 |
| Mannan, SB | 1 |
| Johura, FT | 1 |
| Islam, MT | 1 |
| Sadique, A | 1 |
| Watanabe, H | 1 |
| Sack, RB | 1 |
| Huq, A | 1 |
| Colwell, RR | 1 |
| Cravioto, A | 1 |
| Alam, M | 1 |
| Taneja, N | 1 |
| Biswal, M | 1 |
| Tarai, B | 1 |
| Sharma, M | 1 |
| Uylangco, C | 1 |
| Santiago, L | 1 |
| Pescante, M | 1 |
| Menday, P | 1 |
| Christensen, O | 1 |
| Black, RE | 1 |
| Albert, MJ | 1 |
| Bhuiyan, NA | 1 |
| Talukder, KA | 1 |
| Faruque, AS | 1 |
| Nahar, S | 1 |
| Faruque, SM | 1 |
| Ansaruzzaman, M | 1 |
| Rahman, M | 1 |
| Neumann, S | 1 |
| Grahlow, WD | 1 |
| Woodward, WE | 1 |
| Chevrel, B | 1 |
| Dutta, JK | 1 |
| Santhanam, S | 1 |
| Misra, BS | 1 |
| Ray, SN | 1 |
| Uylangco, CV | 1 |
| Soriano, VB | 1 |
| Pastore, G | 1 |
| Rizzo, G | 1 |
| Fera, G | 1 |
| Schiraldi, O | 1 |
| Dupont, MJ | 1 |
| Jouvenot, M | 1 |
| Couetdic, G | 1 |
| Michel-Briand, Y | 1 |
| Cash, RA | 1 |
| Northrup, RS | 1 |
| Mizanur Rahman, AS | 1 |
1 review available for trimethoprim and Vibrio cholerae Infection
| Article | Year |
|---|---|
The prophylaxis and therapy of secretory diarrhea.
Topics: Anti-Infective Agents, Urinary; Antidiarrheals; Chloramphenicol; Chlorpromazine; Cholera; Diarrhea; | 1982 |
1 trial available for trimethoprim and Vibrio cholerae Infection
| Article | Year |
|---|---|
Pivmecillinam, co-trimoxazole and oral mecillinam in gastroenteritis due to Vibrio spp.
Topics: Adult; Amdinocillin; Amdinocillin Pivoxil; Child, Preschool; Cholera; Drug Combinations; Enterobacte | 1984 |
17 other studies available for trimethoprim and Vibrio cholerae Infection
| Article | Year |
|---|---|
Identification of Small Molecule Inhibitors of the Pathogen Box against Vibrio cholerae.
Topics: Anti-Bacterial Agents; Cholera; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; | 2021 |
Comparative genomics of Vibrio cholerae O1 isolated from cholera patients in Bangladesh.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bangladesh; Child, Preschool; Cholera; Cholera Toxin; | 2018 |
Molecular Epidemiology and Antibiotic Susceptibility of Vibrio cholerae Associated with a Large Cholera Outbreak in Ghana in 2014.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Cholera; Cholera Toxin; Disease Outbreaks | 2016 |
Mechanism of drug resistance in a clinical isolate of Vibrio fluvialis: involvement of multiple plasmids and integrons.
Topics: Antimalarials; Cholera; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacter | 2009 |
Antibacterial activity of ciprofloxacin and trimethoprim, alone and in combinittion, against Vibrio cholerae O1 biotype El Tor serotype Ogawa isolates.
Topics: Anti-Infective Agents, Urinary; Cholera; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug T | 2009 |
Characterization of two novel gene cassettes, dfrA27 and aadA16, in a non-O1, non-O139 Vibrio cholerae isolate from China.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; China; Cholera; DNA, Bacterial; Drug Resi | 2010 |
Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Typing Techniques; Bangladesh; Base Sequence; | 2012 |
Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Chole | 2005 |
Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal.
Topics: Adult; Anti-Bacterial Agents; Bacterial Capsules; Bangladesh; Cholera; Electrophoresis, Gel, Pulsed- | 1997 |
[Cholera today].
Topics: Acid-Base Equilibrium; Asia; Cholera; Dehydration; Diagnosis, Differential; Drug Combinations; Elect | 1979 |
Comments on the use of trimethoprim-sulfamethoxazole in the treatment of cholera.
Topics: Carrier State; Cholera; Drug Combinations; Humans; Sulfamethoxazole; Tetracycline; Trimethoprim | 1979 |
[Value of intramuscular Bactrim in acute typhoid and cholera infections].
Topics: Acute Disease; Cholera; Drug Therapy, Combination; Humans; Injections, Intramuscular; Sulfamethoxazo | 1979 |
Effect of trimethoprim-sulphamethoxazole on vibrio clearance in cholera (El Tor): a comparative study.
Topics: Chloramphenicol; Cholera; Drug Combinations; Humans; India; Sulfamethoxazole; Tetracycline; Trimetho | 1978 |
Minocycline and co-trimoxazole in the treatment of cholera El Tor.
Topics: Adolescent; Adult; Aged; Cholera; Drug Combinations; Female; Humans; Male; Middle Aged; Minocycline; | 1978 |
Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol.
Topics: Adult; Chloramphenicol; Cholera; Drug Combinations; Drug Evaluation; Feces; Humans; Sulfamethoxazole | 1977 |
Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.
Topics: beta-Lactamases; Chloramphenicol; Cholera; Conjugation, Genetic; Drug Combinations; Drug Resistance, | 1985 |
Trimethoprim and sulfamethoxazole in clinical cholera: comparison with tetracycline.
Topics: Adult; Bangladesh; Child; Cholera; Drug Combinations; Drug Resistance, Microbial; Female; Humans; In | 1973 |